AstraZeneca’s antibody cocktail fails to prevent Covid-19 in study
In a setback for AstraZenca, its antibody cocktail fail to produce any promising results in preventing the coronavirus infection, the company has said in a statement. The cocktail combination showed only 33 per cent efficacy in preventing Covid-19 symptoms in people who had been exposed to the virus. The study looked at about 1,121 unvaccinated adults in the US and UK As many as 23 volunteers who got the drug cocktail developed symptomatic Covid-19 after exposure, compared with 17 cases in the group that got a placebo. Read here
Let's